Global Infectious Disease Diagnostic Market Forecasts to 2023: Industry Analysis, Trend, Market Size

Infectious disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized. It can be based solely on clinical presentation or more rigorous diagnostic tests, such as culturing of the infectious agent, microscopy, biochemical screens and molecular methods.

In 2014, the size of the Global Infectious Disease Diagnostic Market was valued nearly USD 12,430 million. While in 2015, size of the infectious disease diagnostic market surpassed USD 12,900 million. The global infectious disease diagnostic market is projected to grow with a CAGR between 7.5 % and 8.0% during 2016-2022 and surpass USD 20 billion by 2022.  Infectious disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized. It can be based solely on clinical presentation or more rigorous diagnostic tests, such as culturing of the infectious agent, microscopy, biochemical screens and molecular methods.

Increasing incidences of infectious diseases, increasing demand for advanced technologies in treatment of infectious disease, and high investment in R&D activities from government and private organizations are considered to be the key factors fueling the growth of infectious disease diagnostic market. However, lack of awareness of novel diagnostic technologies, cost associated with the IDD treatment and stringent government regulatory guidelines are the prime factors restraining the growth of this growth. Moreover, companies operating in the market, which are focusing on developing novel diagnostics as well as initiatives taken by government and private organizations pertaining to diagnosis of the infectious diseases among the people provides more opportunities for the market to grow over the forecast period.



Segments Covered:

The report segments covered the infectious disease diagnostic market by product, by technology, by application and by end-users. Market segmentation based on product type includes instruments, reagents and software & services. Moreover, market segmentation based on technology type includes conventional technology, biochemical technology and molecular technology. While, market segmentation based on application includes bacterial infection, viral infection, CNS infection, cardiovascular infection, fungal infection, sexually transmitted disease and others. Furthermore, the global infectious disease diagnostic market based on end-users is segmented into diagnostic laboratories, academic and medical institutes, Hospitals and surgical centers, ambulatory clinic and home healthcare.

Geographic Coverage and Analysis:

The report provides regional analysis covering geographies such as North America, Europe, Asia Pacific, Latin America and Rest of the World (Row). North America had the largest market share in the global infectious disease diagnostic market owing more than 50% of share in 2014 and 2015. North America and European countries have high adoption of end infectious disease diagnostic with the help of molecular technologies. This increasing adoption of molecular technologies is anticipated to boost the growth of this market in the developed regions. Moreover, Asia Pacific is expected to be the most attractive market and is anticipated to grow at a highest CAGR over the forecast period. Emerging economies such as India and China with increasing urbanization are expected to augment the growth in this market.

Companies Profiled:

The companies covered in the report include

 	
Becton Dickinson and Company
 	
Cepheid, Inc.
 	
Roche Diagnostics
 	
Thermo Fischer Scientific, Inc.
 	
Abbott Laboratories
 	
Bio-Rad Laboratories
 	
BioMerieux
 	
Hologic, Inc.
 	
Danaher Corp.
 	
Affymetrix, Alere, Inc.
 	
DiaSorin, Quidel Corp.
 	
Trinity Biotech
 	
Qiagen
 	
Chembio Diagnostic Systems
 	
OraSure Technologies
 	
Meridian Bioscience
 	
Beckman Coulter
 	
Ortho-Clinic Diagnostics.